WebNov 3, 2024 · Roche is applying its scientific expertise to expand its haematology clinical development programme by exploring additional blood diseases and bringing innovations that address the various... WebTake control of your workflow and workday. The cobas® 4800 System fully automates sample preparation with real-time polymerase chain reaction (PCR) technology for amplification and detection. The cobas® 4800 System offers high lab workflow efficiency, a consolidated assay menu, and the confident results you expect to consistently deliver …
The IVD Market in 2024: $130 Billion and Growing
WebAug 24, 2024 · SEATTLE, Aug. 24, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced a... WebRoche continues to expand its test offerings in frontier areas. In May 2024, Roche launched its RUO suite of Avenio brand circulating cell-free DNA assays outside the U.S. ... also collaborated to obtain FDA market to connect the VITROS 3600 System to the Power Processor to run infectious disease tests. Roche Diagnostics is the largest ... guts demon slayer
Helping to transform the experience of patients with rare …
WebApr 11, 2024 · Inclusion Criteria: Male or female newborn infant aged <20 days at first dose; Newborn infants with genetic diagnosis of 5q-autosomal recessive SMA or newborn infants identified as positive for SMA via newborn screening or via prenatal testing. WebFeb 10, 2024 · FDA has granted breakthrough device designation to a clutch of cardiovascular disease products, part of a wider batch of breakthrough designations that include products in development at companies including Roche. On Monday, FDA awarded breakthrough device status to Puzzle Medical Devices’ minimally invasive transcatheter … WebThe infectious disease landscape is ever-changing. Outbreaks, mutations, emerging pathogens, and growing resistances (e.g. to antibiotics) place significant pressures on … box truck paint